Adult cancer pain.
作者信息
Swarm Robert, Abernethy Amy Pickar, Anghelescu Doralina L, Benedetti Costantino, Blinderman Craig D, Boston Barry, Cleeland Charles, Coyle Nessa, Deleon-Casasola Oscar A, Eilers June G, Ferrell Betty, Janjan Nora A, Karver Sloan Beth, Levy Michael H, Lynch Maureen, Moryl Natalie, Murphy Barbara A, Nesbit Suzanne A, Oakes Linda, Obbens Eugenie A, Paice Judith A, Rabow Michael W, Syrjala Karen L, Urba Susan, Weinstein Sharon M
出版信息
J Natl Compr Canc Netw. 2010 Sep;8(9):1046-86. doi: 10.6004/jnccn.2010.0076.
Abstract
摘要
相似文献
1
Adult cancer pain.
J Natl Compr Canc Netw. 2010 Sep;8(9):1046-86. doi: 10.6004/jnccn.2010.0076.
2
National Comprehensive Cancer network adult pain guidelines.
J Pain Palliat Care Pharmacother. 2006;20(2):94.
3
Management of cancer pain.
Clin Adv Hematol Oncol. 2012 Dec;10(12):829-31.
4
Controlling the pain of cancer.
Sci Am. 1996 Sep;275(3):164-5. doi: 10.1038/scientificamerican0996-164.
5
[The guideline "Pain in cancer' is there. Now we still need the implementation].
Ned Tijdschr Geneeskd. 2009 Mar 21;153(12):535-7.
6
Advances in cancer pain management in 2005.
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S126. doi: 10.1016/j.ygyno.2005.07.058.
7
Cancer pain management.
Clin Adv Hematol Oncol. 2005 Jan;3(1):30-2.
8
Chronic cancer pain. National Cancer Pain Coalition.
J Pract Nurs. 1996 Dec;46(4):13-6, 43.
9
[Treatment of cancer-related bone pain].
Med Monatsschr Pharm. 2016 Jan;39(1):40-2.
10
Management of cancer pain: ESMO clinical recommendations.
Ann Oncol. 2007 Apr;18 Suppl 2:ii92-4. doi: 10.1093/annonc/mdm053.
引用本文的文献
1
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
Mol Clin Oncol. 2024 Nov 29;22(2):14. doi: 10.3892/mco.2024.2809. eCollection 2025 Feb.
2
Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal.
J Oncol Pharm Pract. 2023 Dec;29(8):2049-2056. doi: 10.1177/10781552231205025. Epub 2023 Oct 17.
3
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
Oncol Lett. 2023 Jul 4;26(2):355. doi: 10.3892/ol.2023.13941. eCollection 2023 Aug.
4
Psychological Evaluation of Patients With Cancer Presenting to the Emergency Department With Pain: Independent Predictors of Worse Pain Severity, Interference, and Higher Hourly Opioid Administration.
JCO Oncol Pract. 2022 Oct;18(10):e1648-e1660. doi: 10.1200/OP.22.00142. Epub 2022 Aug 22.
5
Pain management practices for outpatients with breast cancer.
Explor Res Clin Soc Pharm. 2022 Jul 4;6:100155. doi: 10.1016/j.rcsop.2022.100155. eCollection 2022 Jun.
6
Lidocaine Infusion for the Management of Postoperative Pain and Delirium (LIMPP): protocol for a randomised control trial.
BMJ Open. 2022 Jun 6;12(6):e059416. doi: 10.1136/bmjopen-2021-059416.
7
Comparative Analysis of the Efficacy and Safety of Different Traditional Chinese Medicine Injections in the Treatment of Cancer-Related Pain: A Bayesian Network Meta-Analysis.
Front Pharmacol. 2022 Feb 7;12:803676. doi: 10.3389/fphar.2021.803676. eCollection 2021.
8
Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients.
Transl Cancer Res. 2019 Feb;8(1):279-289. doi: 10.21037/tcr.2019.01.36.
9
Chronic pain severity, impact, and opioid use among patients with cancer: An analysis of biopsychosocial factors using the CHOIR learning health care system.
Cancer. 2021 Sep 1;127(17):3254-3263. doi: 10.1002/cncr.33645. Epub 2021 Jun 1.
10
Clinical pain management by a multidisciplinary palliative care team: Experience from a tertiary cancer center in China.
Medicine (Baltimore). 2020 Nov 25;99(48):e23312. doi: 10.1097/MD.0000000000023312.
本文引用的文献
1
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
J Clin Oncol. 2010 May 10;28(14):2423-9. doi: 10.1200/JCO.2009.25.0894. Epub 2010 Apr 12.
2
Opioid switching and rotation in primary care: implementation and clinical utility.
Curr Med Res Opin. 2009 Sep;25(9):2133-50. doi: 10.1185/03007990903120158.
3
A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer.
J Palliat Med. 2008 May;11(4):575-81. doi: 10.1089/jpm.2007.0178.
4
Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia.
J Opioid Manag. 2007 May-Jun;3(3):167-70. doi: 10.5055/jom.2007.0055.
5
A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.
Am J Hosp Palliat Care. 2007 Feb-Mar;24(1):13-9. doi: 10.1177/1049909106295431.
6
Modafinil: is it ready for prime time?
J Opioid Manag. 2006 May-Jun;2(3):130-6. doi: 10.5055/jom.2006.0022.
7
Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
Am J Ther. 2006 Nov-Dec;13(6):534-42. doi: 10.1097/01.mjt.0000253850.86480.fb.
8
Racial and ethnic disparities in pain management in the United States.
J Nurs Scholarsh. 2006;38(3):225-33. doi: 10.1111/j.1547-5069.2006.00107.x.
9
Atypical antipsychotics in the management of delirium: a review of the empirical literature.
Palliat Support Care. 2005 Sep;3(3):227-37. doi: 10.1017/s1478951505050352.
10
Analgesic effect of gefitinib in the treatment of non-small cell lung cancer.
J Support Oncol. 2006 Mar;4(3):111.
Zotero 插件